Søren Gade Jensen
Chairman bei Tecleaf ApS
Profil
Søren Gade Jensen is currently the Chairman of Tecleaf ApS, Director of Samfonden, and Director of Fulton Foundation.
He previously served as an Independent Director for Allarity Therapeutics A and is set to serve as an Independent Director for Allarity Therapeutics, Inc. from 2021 to 2023.
He graduated from the University of Aarhus.
Aktive Positionen von Søren Gade Jensen
Unternehmen | Position | Beginn |
---|---|---|
Tecleaf ApS | Chairman | - |
Samfonden | Director/Board Member | - |
Fulton Foundation | Director/Board Member | - |
Ehemalige bekannte Positionen von Søren Gade Jensen
Unternehmen | Position | Ende |
---|---|---|
ALLARITY THERAPEUTICS, INC. | Director/Board Member | 04.02.2023 |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Director/Board Member | - |
Ausbildung von Søren Gade Jensen
University of Aarhus | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ALLARITY THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Health Technology |
Tecleaf ApS | |
Samfonden | |
Fulton Foundation |